Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rodney J Scott

Showing results (61-70 of 461) with videos related to

Pageof 47
Sort By:
Journal of Biochemical and Biophysical Methods|March 7, 2002
Mutation analysis of MLH1 and MSH2 genes performed by denaturing high-performance liquid chromatographyGrzegorz Kurzawski, Krzysztof Safranow, Janina Suchy, et al.
Hereditary Cancer in Clinical Practice|May 22, 2010
MSH6 and PMS2 mutation positive Australian Lynch syndrome families: novel mutations, cancer risk and age of diagnosis of colorectal cancerBente A Talseth-Palmer, Mary McPhillips, Claire Groombridge, et al.
ANZ Journal of Surgery|June 10, 2026
A Novel Blood-Based Screening Test for Colorectal Cancer Using Raman SpectroscopyJett Karolewski, Georgia Carroll, Rosemary Carroll, et al.
European Journal of Human Genetics : EJHG|December 15, 2011
8q23.3 and 11q23.1 as modifying loci influencing the risk for CRC in Lynch syndromeBente A Talseth-Palmer, Rodney J Scott, Hans F A Vasen, et al.
Hereditary Cancer in Clinical Practice|March 7, 2014
Dupuytren's disease and the risk of malignant neoplasmsAndrzej Zyluk, Katarzyna Paszkowska-Szczur, Satish Gupta, et al.
Cancer Genetics|November 21, 2017
Detection of complex genomic signatures associated with risk in plasma cell disordersNadine K Berry, Amanda Dixon-McIver, Rodney J Scott, et al.
BMC Research Notes|August 20, 2008
Whole genome amplification and its impact on CGH array profilesBente A Talseth-Palmer, Nikola A Bowden, Alyssa Hill, et al.
Carcinogenesis|November 21, 2015
The presence of the intron 3 16 bp duplication polymorphism of p53 (rs17878362) in breast cancer is associated with a low Δ40p53:p53 ratio and better outcomeBrianna C Morten, Michelle W Wong-Brown, Rodney J Scott, et al.
Clinical Epigenetics|February 20, 2018
Letter to the editor: blood processing and sample storage have negligible effects on methylationKira Groen, Rodney A Lea, Vicki E Maltby, et al.
Frontiers in Immunology|January 10, 2022
Endocannabinoid System as a Promising Therapeutic Target in Inflammatory Bowel Disease - A Systematic ReviewSzymon Hryhorowicz, Marta Kaczmarek-Ryś, Aleksandra Zielińska, et al.
Pageof 47

Showing results (61-70 of 461) with videos related to

Sort By:
Pageof 47
Journal of Biochemical and Biophysical Methods|March 7, 2002
Mutation analysis of MLH1 and MSH2 genes performed by denaturing high-performance liquid chromatographyGrzegorz Kurzawski, Krzysztof Safranow, Janina Suchy, et al.
Hereditary Cancer in Clinical Practice|May 22, 2010
MSH6 and PMS2 mutation positive Australian Lynch syndrome families: novel mutations, cancer risk and age of diagnosis of colorectal cancerBente A Talseth-Palmer, Mary McPhillips, Claire Groombridge, et al.
ANZ Journal of Surgery|June 10, 2026
A Novel Blood-Based Screening Test for Colorectal Cancer Using Raman SpectroscopyJett Karolewski, Georgia Carroll, Rosemary Carroll, et al.
European Journal of Human Genetics : EJHG|December 15, 2011
8q23.3 and 11q23.1 as modifying loci influencing the risk for CRC in Lynch syndromeBente A Talseth-Palmer, Rodney J Scott, Hans F A Vasen, et al.
Hereditary Cancer in Clinical Practice|March 7, 2014
Dupuytren's disease and the risk of malignant neoplasmsAndrzej Zyluk, Katarzyna Paszkowska-Szczur, Satish Gupta, et al.
Cancer Genetics|November 21, 2017
Detection of complex genomic signatures associated with risk in plasma cell disordersNadine K Berry, Amanda Dixon-McIver, Rodney J Scott, et al.
BMC Research Notes|August 20, 2008
Whole genome amplification and its impact on CGH array profilesBente A Talseth-Palmer, Nikola A Bowden, Alyssa Hill, et al.
Carcinogenesis|November 21, 2015
The presence of the intron 3 16 bp duplication polymorphism of p53 (rs17878362) in breast cancer is associated with a low Δ40p53:p53 ratio and better outcomeBrianna C Morten, Michelle W Wong-Brown, Rodney J Scott, et al.
Clinical Epigenetics|February 20, 2018
Letter to the editor: blood processing and sample storage have negligible effects on methylationKira Groen, Rodney A Lea, Vicki E Maltby, et al.
Frontiers in Immunology|January 10, 2022
Endocannabinoid System as a Promising Therapeutic Target in Inflammatory Bowel Disease - A Systematic ReviewSzymon Hryhorowicz, Marta Kaczmarek-Ryś, Aleksandra Zielińska, et al.
Pageof 47